Relation of serum vitamin A levels to all-cause and cause-specific mortality among older adults in the NHANES III population

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 11, 2014, Pages 1197-1203

  Min, K B ^a   Min, J Y ^b  

^a Ajou University School of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Cardiovascular disease; Coronary heart disease; Nutrition; Retinol

Indexed keywords

BETA CAROTENE; RETINOL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR SYSTEM; CLINICAL FEATURE; CORONARY ARTERY DISEASE; EDUCATION; ETHNICITY; FEMALE; GENDER; HUMAN; MALE; MIDDLE AGED; RISK FACTOR; VERY ELDERLY; VITAMIN BLOOD LEVEL;

EID: 84909643901     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2014.06.004     Document Type: Article

References (29)

1. Penniston K.L., Tanumihardjo S.A. The acute and chronic toxic effects of vitamin A. Am J Clin Nutr 2006, 83:191-201.
2. Brazionis L., Walker K.Z., Itsiopoulos C., O'Dea K. Plasma retinol: a novel marker for cardiovascular disease mortality in Australian adults. Nutr Metab Cardiovasc Dis NMCD 2012, 22:914-920.
3. De Keyser J., De Klippel N., Merkx H., Vervaeck M., Herroelen L. Serum concentrations of vitamins A and E and early outcome after ischaemic stroke. Lancet 1992, 339:1562-1565.
4. Kalousova M., Kubena A.A., Kostirova M., Vinglerova M., Ing O.M., Dusilova-Sulkova S., et al. Lower retinol levels as an independent predictor of mortality in long-term hemodialysis patients: a prospective observational cohort study. Am J Kidney Dis The Off J Natl Kidney Found 2010, 56:513-521.
5. Rock E., Winklhofer-Roob B.M., Ribalta J., Scotter M., Vasson M.P., Brtko J., et al. Vitamin A, vitamin E and carotenoid status and metabolism during ageing: functional and nutritional consequences (VITAGE PROJECT). Nutr Metab Cardiovasc Dis NMCD 2001, 11:70-73.
6. Cebi A., Kaya Y., Gungor H., Demir H., Yoruk I.H., Soylemez N., et al. Trace elements, heavy metals and vitamin levels in patients with coronary artery disease. Int J Med Sci 2011, 8:456-460.
7. Polidori M.C., Pratico D., Parente B., Mariani E., Cecchetti R., Yao Y., et al. Elevated lipid peroxidation biomarkers and low antioxidant status in atherosclerotic patients with increased carotid or iliofemoral intima media thickness. J Investig Med The Off Publ Am Fed Clin Res 2007, 55:163-167.
8. Gey K.F., Ducimetiere P., Evans A., Amouyel P., Arveiler D., Ferrieres J., et al. Low plasma retinol predicts coronary events in healthy middle-aged men: the PRIME Study. Atherosclerosis 2010, 208:270-274.
9. Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A., et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl J Med 1996, 334:1150-1155.
10. Cartmel B., Dziura J., Cullen M.R., Vegso S., Omenn G.S., Goodman G.E., et al. Changes in cholesterol and triglyceride concentrations in the Vanguard population of the Carotene and Retinol Efficacy Trial (CARET). Eur J Clin Nutr 2005, 59:1173-1180.
11. Huk D.J., Hammond H.L., Kegechika H., Lincoln J. Increased dietary intake of vitamin A promotes aortic valve calcification invivo. Arterioscler Thromb Vasc Biol 2013, 33:285-293.
12. Ansari E.A., Sahni K., Etherington C., Morton A., Conway S.P., Moya E., et al. Ocular signs and symptoms and vitamin A status in patients with cystic fibrosis treated with daily vitamin A supplements. Br J Ophthalmol 1999, 83:688-691.
13. Centers for Disease Control and Prevention Analytic and reporting guidelines: the third National Health and Nutrition Examination Survey, NHANES III (1988-1994) 1996, Available from:, [accessed 03.10.13]. http://www.cdc.gov/nchs/data/nhanes/nhanes3/nh3gui.pdf.
14. National Center for Health Statistics NHANES III linked mortality file 2006, Available from:, [accessed 30.10.12]. http://www.cdc.gov/nchs/data_access/data_linkage/mortality/nhanes3_linkage.htm.
15. Gunter E.W., Lewis B.L., Koncikowski S.M. Laboratory methods used for the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 1996, US Department of Health and Human Services, Atlanta, GA.
16. Anderson R.N., Minino A.M., Hoyert D.L., Rosenberg H.M. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics. Natl Vital Stat Syst 2001, 49:1-32.
17. Goyal A., Terry M.B., Siegel A.B. Serum antioxidant nutrients, vitamin a, and mortality in U.S. adults. Cancer Epidemiol Biomarkers Prev 2013, 22:2202-2211.
18. Delport R., Ubbink J.B., Human J.A., Becker P.J., Myburgh D.P., Vermaak W.J. Antioxidant vitamins and coronary artery disease risk in South African males. Clin Chimica Acta Int J Clin Chem 1998, 278:55-60.
19. Michaelsson K., Lithell H., Vessby B., Melhus H. Serum retinol levels and the risk of fracture. N Engl J Med 2003, 348:287-294.
20. Newcomer M.E., Ong D.E. Plasma retinol binding protein: structure and function of the prototypic lipocalin. Biochim Biophys Acta 2000, 1482:57-64.
21. Ingelsson E., Sundstrom J., Melhus H., Michaelsson K., Berne C., Vasan R.S., et al. Circulating retinol-binding protein 4, cardiovascular risk factors and prevalent cardiovascular disease in elderly. Atherosclerosis 2009, 206:239-244.
22. Mallat Z., Simon T., Benessiano J., Clement K., Taleb S., Wareham N.J., et al. Retinol-binding protein 4 and prediction of incident coronary events in healthy men and women. J Clin Endocrinol Metab 2009, 94:255-260.
23. Cabre A., Lazaro I., Girona J., Manzanares J., Marimon F., Plana N., et al. Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes. J Intern Med 2007, 262:496-503.
24. Bobbert T., Raila J., Schwarz F., Mai K., Henze A., Pfeiffer A.F., et al. Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima media thickness. Atherosclerosis 2010, 213:549-551.
25. Alkharfy K.M., Al-Daghri N.M., Vanhoutte P.M., Krishnaswamy S., Xu A. Serum retinol-binding protein 4 as a marker for cardiovascular disease in women. PloS One 2012, 7:e48612.
26. Infante M., Pastorino U., Chiesa G., Bera E., Pisani P., Valente M., et al. Laboratory evaluation during high-dose vitamin A administration: a randomized study on lung cancer patients after surgical resection. J Cancer Res Clin Oncol 1991, 117:156-162.
27. Tangrea J.A., Adrianza E., Helsel W.E., Taylor P.R., Hartman A.M., Peck G.L., et al. Clinical and laboratory adverse effects associated with long-term, low-dose isotretinoin: incidence and risk factors. The Isotretinoin-Basal Cell Carcinomas Study Group. Cancer Epidemiol Biomarkers Prev a Publ Am Assoc Cancer Res Cosponsored by Am Soc Prev Oncol 1993, 2:375-380.
28. Grundy S.M. Cholesterol and coronary heart disease. A new era. JAMA: The J Am Med Assoc 1986, 256:2849-2858.
29. Lloyd-Jones D.M., Martin D.O., Larson M.G., Levy D. Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med 1998, 129:1020-1026.